Exosome RNA Exosome RNA Research & Industry News
Epic Sciences, Inc. and its research partners today report the use of the company’s new circulating tumor cell (CTC) homologous recombination deficiency (HRD) liquid biopsy assay for the prediction of...
Read More »Epic sciences unveils new liquid biopsy test to predict sensitivity to PARP inhibitors in prostate cancer trial
